Differential role of Jak-STAT signaling in retinal degenerations

Marijana Samardzija1, Andreas Wenzel, Svenja Aufenberg

  • 1Laboratory for Retinal Cell Biology, Department Ophthalmology, University Hospital, Frauenklinikstrasse 24, 8091 Zürich, Switzerland.

Insights

Retinal degeneration involves interleukin-6 family proteins and the Jak-STAT pathway. Inhibiting Jak2 protected photoreceptors in induced but not inherited degeneration, suggesting varied cell death pathways.

Area of Science:

  • Ophthalmology
  • Molecular Biology
  • Cell Biology

Background:

  • Retinal degeneration causes significant vision loss.
  • Understanding molecular mechanisms is crucial for developing treatments.
  • Current therapeutic strategies require deeper insight into cellular responses.

Purpose of the Study:

  • To investigate the molecular pathways activated during retinal degeneration.
  • To explore the role of the interleukin-6 (IL-6) family and Jak-STAT signaling.
  • To determine the therapeutic potential of Jak2 inhibition in different degeneration models.

Main Methods:

  • Utilized three distinct mouse models of retinal degeneration (induced and inherited).
  • Analyzed the expression of LIF and CLC, IL-6 family members.
  • Examined the activation of the Jak-STAT signaling pathway and suppressors of cytokine signaling.
  • Assessed the impact of Jak2 inhibition on photoreceptor survival.
  • Investigated differential activation of the Akt pathway.

Main Results:

  • Retinal degeneration induced LIF and CLC expression and activated Jak-STAT signaling.
  • Suppressors of cytokine signaling were upregulated as a negative feedback mechanism.
  • Jak2 inhibition provided photoreceptor protection in induced but not inherited degeneration models.
  • Differential Akt pathway activation indicated varied cell death/survival mechanisms.
  • Induced proteins were primarily expressed in non-photoreceptor retinal cells.

Conclusions:

  • Photoreceptor injury triggers signaling to inner retinal cells, influencing cell fate.
  • Distinct molecular pathways mediate cell death and survival in different retinal degeneration models.
  • Targeting Jak2 may offer therapeutic benefits for specific types of retinal degeneration.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...